Regeneron Pharmaceuticals, inc.
Proposal 1a.
Election of Director: Bonnie L. Bassler, Ph.D.
Caisse vote:
Against
Applicable policy or principle:
PDV_01
Proposal 1b.
Election of Director: Michael S. Brown, M.D.
Caisse vote:
Against
Applicable policy or principle:
PDV_01
Proposal 1c.
Election of Director: Leonard S. Schleifer, M.D., Ph.D.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1d.
Election of Director: George D. Yancopoulos, M.D., Ph.D.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 2.
Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 3.
Proposal to approve, on an advisory basis, executive compensation.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 4.
Proposal to approve an amendment to the Company's Certificate of Incorporation to declassify the board of directors.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 5a.
Proposal to approve an amendment to Article IV, Section 2(e)(8) of the Certificate of Incorporation.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 5b.
Proposal to approve an amendment to Article VI of the Certificate of Incorporation.
Caisse vote:
For
Applicable policy or principle:
PDV_01